Search Results - "Hoglinger, Gunter"
-
1
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Published in Movement disorders (01-06-2017)“…ABSTRACT Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of…”
Get full text
Journal Article -
2
A genome-wide association study in multiple system atrophy
Published in Neurology (11-10-2016)“…OBJECTIVE:To identify genetic variants that play a role in the pathogenesis of multiple system atrophy (MSA), we undertook a genome-wide association study…”
Get full text
Journal Article -
3
Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
Published in Journal of cerebral blood flow and metabolism (01-11-2021)“…The novel tau-PET tracer [18F]PI-2620 detects the 3/4-repeat-(R)-tauopathy Alzheimer’s disease (AD) and the 4R-tauopathies corticobasal syndrome (CBS) and…”
Get full text
Journal Article -
4
SEND-PD in Parkinsonian Syndromes: Results of a Monocentric Cross-Sectional Study
Published in Neuropsychiatric disease and treatment (01-10-2024)“…Neuropsychiatric symptoms in particular impair health-related quality of life (QoL) of patients with Parkinson's disease and atypical Parkinsonian syndromes…”
Get full text
Journal Article -
5
The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations
Published in Movement disorders (01-12-2022)Get full text
Journal Article -
6
An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability
Published in Acta neuropathologica communications (14-11-2016)“…Postural instability and supranuclear gaze palsy represent the key symptoms of Richardson's syndrome, the most frequent clinical manifestation of progressive…”
Get full text
Journal Article -
7
Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations
Published in Parkinsonism & related disorders (01-03-2019)“…Progressive supranuclear palsy (PSP) -Richardson's Syndrome and Corticobasal Syndrome (CBS) are the two classic clinical syndromes associated with underlying…”
Get full text
Journal Article -
8
Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupe
Published in Movement disorders (01-12-2005)“…Atypical parkinsonism in Guadeloupe has been associated with the consumption of fruit and infusions or decoctions prepared from leaves of Annona muricata L…”
Get full text
Journal Article -
9
Neuropathology of progressive supranuclear palsy after treatment with tilavonemab – Author's reply
Published in Lancet neurology (01-10-2021)Get full text
Journal Article -
10
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
Published in Lancet neurology (01-07-2017)“…Summary Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinsonism, is now recognised as a range of motor and…”
Get full text
Journal Article -
11
Fenazaquin aggravates tau pathology in P301S transgenic mice
Published in Neurotoxicology and teratology (01-05-2015)Get full text
Journal Article -
12
Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies
Published in Nature reviews. Neurology (01-10-2021)“…Tauopathies are classified according to whether tau deposits predominantly contain tau isoforms with three or four repeats of the microtubule-binding domain…”
Get full text
Journal Article -
13
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
Published in Lancet neurology (01-02-2024)“…With the hope that disease-modifying treatments could target the molecular basis of Parkinson's disease, even before the onset of symptoms, we propose a…”
Get full text
Journal Article -
14
CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP
Published in Neurology (23-01-2018)“…OBJECTIVETo determine the ability of CSF biomarkers to predict disease progression in progressive supranuclear palsy (PSP). METHODSWe compared the ability of…”
Get full text
Journal Article -
15
The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases
Published in Movement disorders (01-12-2014)“…The phenotypic variability of progressive supranuclear palsy (PSP) may account for its frequent misdiagnosis, in particular in early stages of the disease…”
Get full text
Journal Article -
16
Differential effects of social and physical environmental enrichment on brain plasticity, cognition, and ultrasonic communication in rats
Published in Journal of comparative neurology (1911) (01-06-2016)“…ABSTRACT Environmental enrichment (EE) exerts beneficial effects on brain plasticity, cognition, and anxiety/depression, leading to a brain that can counteract…”
Get full text
Journal Article -
17
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
Published in Movement disorders (01-07-2017)“…ABSTRACT PSP is a pathologically defined neurodegenerative tauopathy with a variety of clinical presentations including typical Richardson's syndrome and other…”
Get full text
Journal Article -
18
Progression of brain atrophy in PSP and CBS over 6 months and 1 year
Published in Neurology (08-11-2016)“…OBJECTIVE:To examine the utility and reliability of volumetric MRI in measuring disease progression in the 4 repeat tauopathies, progressive supranuclear palsy…”
Get full text
Journal Article -
19
Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion
Published in Cell death & disease (17-09-2021)“…Dopaminergic (DA) cell death in Parkinson’s disease (PD) is associated with the gradual appearance of neuronal protein aggregates termed Lewy bodies (LBs) that…”
Get full text
Journal Article -
20
Prothrombotic immune thrombocytopenia after COVID-19 vaccination
Published in Blood (29-07-2021)“…We report 5 cases of prothrombotic immune thrombocytopenia after exposure to the ChAdOx1 vaccine (AZD1222, Vaxzevria) against severe acute respiratory syndrome…”
Get full text
Journal Article